KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Vertex Pharmaceuticals' Other Non-Current Assets rose 1088.67% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 1088.67%. This contributed to the annual value of $999.3 million for FY2024, which is 1161.62% up from last year.
  • Latest data reveals that Vertex Pharmaceuticals reported Other Non-Current Assets of $1.1 billion as of Q3 2025, which was up 1088.67% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Other Non-Current Assets ranged from a high of $1.1 billion in Q3 2025 and a low of $49.3 million during Q1 2021
  • In the last 5 years, Vertex Pharmaceuticals' Other Non-Current Assets had a median value of $442.7 million in 2023 and averaged $541.7 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first plummeted by 7971.53% in 2021, then surged by 28617.89% in 2023.
  • Over the past 5 years, Vertex Pharmaceuticals' Other Non-Current Assets (Quarter) stood at $110.8 million in 2021, then soared by 269.68% to $409.6 million in 2022, then skyrocketed by 118.58% to $895.3 million in 2023, then grew by 11.62% to $999.3 million in 2024, then rose by 9.88% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $1.1 billion for Q2 2025, and $1.0 billion during Q1 2025.